Viewing Study NCT00110994


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT00110994
Status: COMPLETED
Last Update Posted: 2015-06-08
First Post: 2005-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Melanoma View
Keywords: